The US journal "Science" has named the development of the drug Lenacapavir as this year's "Breakthrough of the Year". The ...

Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

Gilead Sciences’ top money maker Biktarvy has been the company’s crown jewel for years now, but with the HIV med inching ...

As far as affordable ARVs for HIV/AIDS patents are concerned, one recalls a successful civil society movement in South Africa ...

Baguio City has been averaging seven new HIV cases monthly since January, while Benguet province reports three cases per ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living ...

The Fiji Medical Association is making an urgent call to the Ministry of Health to declare a HIV outbreak in the country and ...

Robert F. Kennedy Jr., Donald Trump’s pick to lead the US Department of Health and Human Services, has been vocally ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination.